Nalaganje...
Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer
Rucaparib is a potent small-molecule inhibitor of poly (ADP-ribose) polymerase (PARP) proteins (PARP-1, PARP-2 and PARP-3) that play an important role in repairing DNA damage and maintaining genomic stability. Tumors with mutations in BRCA1/2 or other homologous recombination deficiency (HRD) genes...
Shranjeno v:
| izdano v: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868608/ https://ncbi.nlm.nih.gov/pubmed/29606854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S130809 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|